Colorectal Cancer | Specialty

The OncLive Colorectal Cancer condition center page is a comprehensive resource for clinical news and expert insights on colorectal cancer treatment and management, with a focus on novel therapeutic strategies including checkpoint inhibitors and TKIs across lines of therapy. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in colorectal cancer.

Molecular Status and Subsequent Therapies in mCRC

February 25th 2020

Initial Systemic Therapy for Metastatic Colorectal Cancer

February 25th 2020

Continuum of Care in Metastatic Colorectal Cancer

February 25th 2020

Dr. Morris on Treatment Advances Made in BRAF-Mutated mCRC

February 25th 2020

Van K. Morris, MD, discusses the recent progress made in the treatment of patients with BRAF-mutated metastatic colorectal cancer.

Dr. Kopetz on the Rationale and Design of the BEACON CRC Study in mCRC

February 22nd 2020

Scott Kopetz, MD, PhD, FACP, discusses the rationale and primary endpoints of the BEACON CRC study in BRAF V600E–mutant metastatic colorectal cancer.

Research Efforts Poised to Redefine Role of Immunotherapy in mCRC

February 21st 2020

Neil H. Segal, MD, PhD, discusses the current role of immunotherapy in colorectal cancer and the work being done to define its role in earlier-line settings and among patients with microsatellite stable disease.

Ongoing Studies May Clarify Role of ADCs in Gastric Cancer and CRC

February 20th 2020

The approval of fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer is generating hopes that similar strategies also may be effective against HER2-expressing gastric and colorectal cancers, according to a panel of experts in gastrointestinal malignancies.

Dr. Eng on Increasing Awareness for Adolescents/Young Adults With CRC

February 20th 2020

Cathy Eng, MD, FACP, FASCO, discusses the need to increase awareness regarding treating adolescents and young adults with colorectal cancer.

Dr. Lockhart on Dual-Immunotherapy Strategies in CRC

February 18th 2020

A. Craig Lockhart, MD, MHS, professor and associate director for Regional and Strategic Clinical Research Affiliations, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses dual-immunotherapy strategies in colorectal cancer (CRC).

Dr. Corcoran on Targeting HER2 Amplification in CRC

February 14th 2020

Ryan B. Corcoran, MD, PhD, discusses the presence of HER2 amplification in metastatic colorectal cancer.

Dr. Cercek on the Need for Treatment Options in KRAS-Mutated mCRC

February 11th 2020

Andrea Cercek, MD, discusses the need for treatment options in KRAS-mutated metastatic colorectal cancer (mCRC).

Dr. Cercek on the Importance of Molecular Testing in CRC

February 8th 2020

Andrea Cercek, MD, discusses the importance of molecular testing in colorectal cancer.

Novel Therapeutic Targets and Combinations in mCRC

February 8th 2020

MCRC: Future Directions for Molecular-Driven Treatment

February 8th 2020

Immunotherapy for MSI-High/dMMR mCRC

February 8th 2020

Evolution of MSI Testing for mCRC

February 8th 2020

Treatment Strategies for HER2-Amplified mCRC

February 8th 2020

Optimal Therapy for BRAF-Mutated mCRC

February 8th 2020

Impact of BRAF Mutations on Metastatic Colorectal Cancer

February 8th 2020

MCRC: Sequencing Based on RAS Status and Tumor Sidedness

February 8th 2020